BlackRock Inc. reduced its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 0.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,061,228 shares of the business services provider’s stock after selling 19,014 shares during the period. BlackRock Inc. owned approximately 11.59% of Exponent worth $178,468,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. Vanguard Group Inc. grew its position in Exponent by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 2,176,141 shares of the business services provider’s stock worth $129,590,000 after purchasing an additional 81,811 shares during the last quarter. Conestoga Capital Advisors LLC grew its position in Exponent by 15.6% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 727,177 shares of the business services provider’s stock worth $42,394,000 after purchasing an additional 98,280 shares during the last quarter. State Street Corp grew its position in Exponent by 7.1% during the 1st quarter. State Street Corp now owns 614,266 shares of the business services provider’s stock worth $36,583,000 after purchasing an additional 40,833 shares during the last quarter. GW&K Investment Management LLC grew its position in Exponent by 20.4% during the 2nd quarter. GW&K Investment Management LLC now owns 407,557 shares of the business services provider’s stock worth $23,761,000 after purchasing an additional 68,938 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in Exponent by 5.7% during the 1st quarter. Bank of New York Mellon Corp now owns 401,314 shares of the business services provider’s stock worth $23,899,000 after purchasing an additional 21,735 shares during the last quarter. 88.26% of the stock is currently owned by institutional investors.

Exponent, Inc. (NASDAQ EXPO) opened at 75.30 on Thursday. Exponent, Inc. has a 12 month low of $48.42 and a 12 month high of $76.20. The stock has a market capitalization of $1.94 billion, a P/E ratio of 39.04 and a beta of 0.61. The firm’s 50-day moving average is $71.12 and its 200 day moving average is $63.49.

Exponent (NASDAQ:EXPO) last issued its earnings results on Tuesday, July 18th. The business services provider reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.10. The company had revenue of $84.10 million for the quarter, compared to analysts’ expectations of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The firm’s revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.38 earnings per share. On average, equities analysts anticipate that Exponent, Inc. will post $1.97 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 22nd. Shareholders of record on Friday, September 1st were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Wednesday, August 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.12%. Exponent’s dividend payout ratio (DPR) is 43.52%.

WARNING: This report was originally posted by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.dailypolitical.com/2017/10/12/blackrock-inc-lowers-holdings-in-exponent-inc-expo.html.

In other news, insider John Pye sold 3,600 shares of the company’s stock in a transaction dated Monday, July 24th. The shares were sold at an average price of $65.08, for a total transaction of $234,288.00. Following the completion of the transaction, the insider now owns 14,767 shares in the company, valued at $961,036.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Harri Kytomaa sold 12,000 shares of the company’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $66.38, for a total transaction of $796,560.00. Following the transaction, the insider now owns 11,360 shares of the company’s stock, valued at approximately $754,076.80. The disclosure for this sale can be found here. Insiders have sold 80,848 shares of company stock worth $5,425,477 over the last three months. 2.80% of the stock is owned by corporate insiders.

Several brokerages have issued reports on EXPO. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 price objective (up from $69.00) on shares of Exponent in a research report on Wednesday, July 19th. Zacks Investment Research downgraded shares of Exponent from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 19th. BidaskClub raised shares of Exponent from a “strong sell” rating to a “sell” rating in a research report on Wednesday, July 5th. Finally, ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th.

About Exponent

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.